ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2026
Fulminant hepatitis secondary to dengue in pediatric patients: a series of four cases.
Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study reports a case series of four pediatric patients with dengue who developed fulminant hepatitis and acute liver failure requiring transplantation. This study aims to enhance early recognition of dengue-related complications, particularly fulminant hepatitis. The series includes two previously healthy girls, aged one and six years; and two boys, aged 12 and 15 years, with pre-existing hemoglobinopathies. A review was conducted to contextualize these cases with prior reports of dengue-associated fulminant hepatitis in children, focusing on diagnosis and management. All four patients underwent liver transplantation, yet their clinical courses and outcomes were varied. Patient 1, a six-year-old girl, had early warning signs and underwent cadaveric liver transplantation nine days after onset. Patient 2, a one--year-old girl, developed severe disease and received living-donor transplantation 20 days after onset. Both had favorable postoperative outcomes. Patient 3, a 12-year-old boy with SC hemoglobinopathy, underwent transplantation on day seven of illness but died on the fifth postoperative day. Patient 4, a 15-year-old boy with sickle cell anemia, underwent transplantation on day four of symptoms but suffered multiple cardiorespiratory arrests during recovery and died on postoperative day 24. Although rare, dengue can lead to fulminant hepatitis in previously healthy children, with worse outcomes in those with comorbidities. Early recognition of severe manifestations is critical for appropriate management. Larger studies are warranted to identify prognostic factors and optimize decision-making for pediatric patients requiring liver transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.